Development of a new calcilytic for the treatment of inflammatory lung disease

P. Yarova (Cardiff, United Kingdom), M. Schepelmann (Cardiff, United Kingdom), S. Ferla (Cardiff, United Kingdom), P. Huang (Cardiff, United Kingdom), V. Telezhkin (Newcastle upon Tyne, United Kingdom), E. Kidd (Cardiff, United Kingdom), W. Ford (Cardiff, United Kingdom), K. Broadley (Cardiff, United Kingdom), J. Ward (London, United Kingdom), C. Corrigan (London, United Kingdom), P. Kemp (Cardiff, United Kingdom), A. Brancale (Cardiff, United Kingdom), D. Riccardi (Cardiff, United Kingdom)

Source: International Congress 2018 – Basic pharmacology
Session: Basic pharmacology
Session type: Thematic Poster
Number: 1060
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Yarova (Cardiff, United Kingdom), M. Schepelmann (Cardiff, United Kingdom), S. Ferla (Cardiff, United Kingdom), P. Huang (Cardiff, United Kingdom), V. Telezhkin (Newcastle upon Tyne, United Kingdom), E. Kidd (Cardiff, United Kingdom), W. Ford (Cardiff, United Kingdom), K. Broadley (Cardiff, United Kingdom), J. Ward (London, United Kingdom), C. Corrigan (London, United Kingdom), P. Kemp (Cardiff, United Kingdom), A. Brancale (Cardiff, United Kingdom), D. Riccardi (Cardiff, United Kingdom). Development of a new calcilytic for the treatment of inflammatory lung disease. 1060

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: